Editing 2C-C (section)

{{Infobox drug
| Verifiedfields = verified
| Watchedfields = verified
| verifiedrevid = 477216097
| drug_name = 
| image = 2C-C.svg
| width = 200px
| caption = 
| image2 = 2C-C-3d-sticks.png
| width2 = 175px

<!-- Clinical data -->
| pronounce = 
| tradename = 
| Drugs.com = 
| MedlinePlus = 
| licence_CA = 
| licence_EU = 
| DailyMedID = 
| licence_US = 
| pregnancy_AU = 
| pregnancy_category = 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = [[Oral administration|Oral]]
| class = [[Serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]]
| ATC_prefix = 
| ATC_suffix = 

<!-- Legal status -->
| legal_AU = 
| legal_BR = F2
| legal_CA = Schedule III
| legal_DE = Anlage I
| legal_US = Schedule I
| legal_status = 

<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| metabolites = 
| onset = 
| elimination_half-life = 
| duration_of_action = 
| excretion = 

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 88441-14-9
| CAS_supplemental = 
| PubChem = 29979100
| PubChemSubstance = 
| IUPHAR_ligand = 
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21106221
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0RO7MZY2LS
| KEGG = 
| ChEBI = 
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 124733
| NIAID_ChemDB = 
| PDB_ligand = 
| synonyms = 2,5-Dimethoxy-4-chlorophenethylamine; 4-Chloro-2,5-dimethoxyphenethylamine

<!-- Chemical data -->
| IUPAC_name = 2-(4-chloro-2,5-dimethoxyphenyl)ethan-1-amine
| C=10 | H=14 | Cl=1 | N=1 | O=2 
| SMILES = COc1cc(CCN)c(cc1Cl)OC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H14ClNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CGKQFIWIPSIVAS-UHFFFAOYSA-N

<!-- Physical data -->
| melting_point = 220
| melting_high = 221
| melting_notes = ([[hydrochloride]])
}}

'''2C-C''' is a [[Psychedelics, dissociatives and deliriants|psychedelic drug]] of the [[2C (psychedelics)|2C family]]. It was first synthesized by [[Alexander Shulgin]], sometimes used as an [[entheogen]]. In his book ''[[PiHKAL|PiHKAL (Phenethylamines i Have Known And Loved)]]'', Shulgin lists the dosage range as 20–40&nbsp;mg. 2C-C is usually taken orally, but may also be insufflated.<ref name="CitePiHKAL">{{CitePiHKAL}}</ref> 2C-C is [[Controlled Substances Act#Schedule I controlled substances|schedule I]] of section 202(c) of the [[Controlled Substances Act]] in the United States, signed into law as of July, 2012 under the [[Food and Drug Administration Safety and Innovation Act]].<ref>{{cite web|url=http://www.govtrack.us/congress/bills/112/s3187/text|title=S. 3187: Food and Drug Administration Safety and Innovation Act, Subtitle D-Synthetic Drugs|publisher=FDA|date=June 27, 2012|access-date=July 12, 2012|url-status=live|archive-url=https://web.archive.org/web/20120704120359/http://www.govtrack.us/congress/bills/112/s3187/text|archive-date=July 4, 2012}}</ref>

Not much information is known about the toxicity of 2C-C.